thiotepa has been researched along with Blood Protein Disorders in 1 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Blood Protein Disorders: Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulik, GI | 1 |
| Pel'kis, FP | 1 |
1 other study available for thiotepa and Blood Protein Disorders
| Article | Year |
|---|---|
[The effect of antineoplastic alkylating agents on the serum protein fraction of rats with sarcoma 45].
Topics: Alkylating Agents; Animals; Blood Protein Disorders; Blood Protein Electrophoresis; Cyclophosphamide | 1969 |